AstraZeneca plc (AZN) Pops on Upbeat Drug Data

Drugmaker AstraZeneca plc (ADR) (NYSE:AZN) is staring down a key trendline on a drug-data-induced rally

Jul 18, 2016 at 11:12 AM
facebook X logo linkedin


Biotech stock AstraZeneca plc (ADR) (NYSE:AZN) is trading 1.1% higher at $30.59 today, following news that the company's lung cancer treatment, Tagrisso, met its primary endpoint in a Phase 3 trial. The stock has been surrounded by optimism in the options pits, despite giving up 10% year-to date. But these bulls may be on edge, as the shares are running headlong into their overhead 200-day moving average -- a trendline the stock hasn't topped since early January. Still, it looks like AZN may have found a foothold at the round $30 mark, a level that's home to peak call and put open interest in the August series.

As alluded to, options traders have been betting on a bounce, although absolute volume in the equity's options pits has been relatively light. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), more than 34 AZN calls have been bought to open for each put over the past two weeks. What's more, the resulting 10-day call/put volume ratio of 34.16 is seated at a 12-month high.

Analysts have taken a much more cautious view of the stock. Of the four brokerage firms providing coverage, only one recommends buying AZN. Many traders are skeptical, as well. While short interest accounts for just 1% of AZN's available float, these bearish bets have been steadily rising for roughly a year, including a nearly 14% pop during the two most recent reporting periods. Moreover, the 25.3 million shorted shares represent the stock's highest level of short interest since 2002. Should these short sellers begin to back off, or analysts raise their outlooks, a breakout above the 200-day moving average could help AstraZeneca plc (ADR) (NYSE:AZN) extend today's gains.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI